-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Alnylam Pharmaceuticals, Lowers Price Target to $354

Benzinga·10/30/2026 18:15:25
語音播報
TD Cowen analyst Ritu Baral maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and lowers the price target from $482 to $354.